O9 whitepaper pharma control towers mockup

/

/

white paper

How Control Towers Help Pharmaceutical Companies Sense and Respond to Disruptions

Achieve enhanced collaboration and end-to-end visibility by leveraging a Control Tower.

Kyowa Kirin
Intuitive Surgical
CooperVision
ResMed
Philips
Teleflex
Samsung Bioepis
WS Audiology
Olympus
PepsiCo
ExxonMobil
Levi Strauss & Co.
Kyowa Kirin
Intuitive Surgical
CooperVision
ResMed
Philips
Teleflex
Samsung Bioepis
WS Audiology
Olympus
PepsiCo
ExxonMobil
Levi Strauss & Co.
Kyowa Kirin
Intuitive Surgical
CooperVision
ResMed
Philips
Teleflex
Samsung Bioepis
WS Audiology
Olympus
PepsiCo
ExxonMobil
Levi Strauss & Co.

UNLOCKING BILLIONS IN VALUE FOR CLIENTS IN 30+ INDUSTRIES

In this white paper, you’ll learn:

  • Planning and Execution

    Bridging S&OP and S&OE to accelerate optimal responses to internal and external disruptions.

  • End-to-End Visibility

    Experience the benefits of an end-to-end view of operations and establishing a feedback loop between execution and planning.

  • Mitigate Risks

    A control tower allows planners to reposition their operations to reduce risks caused by disruption.

o9 is committed to helping our clients across a variety of industries navigate the risks and opportunities that are inherent in operating large-scale, multi-tier supply chains by continuously enhancing our Digital Brain platform with next-generation technologies and end-to-end planning capabilities.

Chakri Gottemukkala

CEO and Co-Founder

O9 whitepaper pharma control towers mockup

How control towers help pharmaceutical companies sense and respond to disruptions

Achieve enhanced collaboration and end-to-end visibility by leveraging a control tower.